Thermo Fisher Scientific, Inc. TMO recently launched the Applied Biosystems CytoScan HD Accel array — a new chromosomal microarray intended to enhance cytogenetic research lab productivity, efficiency ...
On Oct 17, 2023,Thermo Fisher announced its plans to acquire Olink. The deal, valued at approximately $3.1 billion or 26 per share, represented a 74% premium over Olink’s closing price of $14.98 on ...
Introducing the new CytoScan HD Accel microarray that significantly improves the power and speed of genome-wide copy number analysis using industry-leading Chromosomal Microarray (CMA). The highly ...
UPPSALA, Sweden, July 08, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (OLK) today announced that the UK Competition and Markets Authority (the “CMA”) has unconditionally approved the previously ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results